Tracheobronchopathia osteochondroplastica in the setting of COVID-19

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Tracheobronchopathia osteoplastica (TO) is a rare, benign disease of unknown etiology, primarily affecting the major tracheobronchial tree, characterized by irregular nodular calcifications of the cartilaginous component of the inner wall of the tracheobronchial tree while sparing the posterior wall, leading to progressive narrowing of the airway. We report the case of a 60-year-old male otherwise healthy nonsmoker, who complained of chronic breathing discomfort and recurrent chest infections and was found to have TO according to radiographic, microlaryngoscopic, and biopsy findings. He experienced a flare up with worsening of disease progression after years of being in stable condition, after his infection with SARS-CoV-2.

Cite

CITATION STYLE

APA

Al Omari, A., Al-Qarqaz, W., Khresat, M., & Sataloff, R. T. (2024). Tracheobronchopathia osteochondroplastica in the setting of COVID-19. Ear, Nose and Throat Journal, 103(1_suppl), 98S-101S. https://doi.org/10.1177/01455613221083822

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free